This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Bayer Aktiengesellschaft. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Ute Elias: Innovator in Tetrazole-Substituted Compounds
Introduction
Ute Elias is a notable inventor based in Leverkusen, Germany. She has made significant contributions to the field of chemistry, particularly in the development of novel compounds. Her work has led to advancements in the preparation of tetrazole-substituted anthranilic acid diamide derivatives.
Latest Patents
Ute Elias holds 1 patent for her innovative process titled "Process for preparing a tetrazole-substituted anthranilic acid diamide derivative." This invention relates to a method for producing a tetrazole-substituted anthranilic acid diamide derivative in crystalline form. The process ensures high purity and yield, and it introduces novel solvate crystals with improved filtration properties.
Career Highlights
Elias is associated with Bayer Aktiengesellschaft, a leading global company in the pharmaceutical and life sciences sector. Her work at Bayer has allowed her to focus on innovative chemical processes that have practical applications in various industries.
Collaborations
Throughout her career, Ute Elias has collaborated with esteemed colleagues, including Dirk Havekost and Edith Beckmann. These collaborations have fostered a productive environment for research and development, leading to significant advancements in their field.
Conclusion
Ute Elias exemplifies the spirit of innovation in the chemical industry. Her contributions, particularly in the area of tetrazole-substituted compounds, highlight the importance of research and collaboration in driving scientific progress.